Owens & Minor (OMI) Upgraded by Zacks Investment Research to “Hold”

Owens & Minor (NYSE:OMI) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.

According to Zacks, “Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor’s customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary. “

How to Become a New Pot Stock Millionaire

Other analysts have also recently issued reports about the company. Bank of America started coverage on Owens & Minor in a research note on Tuesday, February 27th. They issued a “buy” rating and a $19.00 price target for the company. ValuEngine cut Owens & Minor from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. Barclays started coverage on Owens & Minor in a research note on Thursday, March 8th. They issued an “underweight” rating and a $16.00 price target for the company. Finally, JPMorgan Chase lowered their price target on Owens & Minor from $21.00 to $20.00 and set an “underweight” rating for the company in a research note on Thursday, February 15th. Six research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $24.28.

Owens & Minor stock traded up $0.35 during trading hours on Wednesday, reaching $15.69. 126,611 shares of the company’s stock traded hands, compared to its average volume of 1,552,020. The company has a current ratio of 1.67, a quick ratio of 0.91 and a debt-to-equity ratio of 0.89. Owens & Minor has a fifty-two week low of $14.26 and a fifty-two week high of $34.97. The company has a market cap of $928.27, a PE ratio of 9.75, a PEG ratio of 0.92 and a beta of 1.06.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings results on Wednesday, February 14th. The company reported $0.35 EPS for the quarter, beating analysts’ consensus estimates of $0.34 by $0.01. The company had revenue of $2.39 billion during the quarter, compared to analysts’ expectations of $2.34 billion. Owens & Minor had a return on equity of 9.63% and a net margin of 0.78%. Owens & Minor’s revenue was up .9% on a year-over-year basis. During the same period in the prior year, the business posted $0.52 EPS. research analysts forecast that Owens & Minor will post 2.06 EPS for the current year.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Alps Advisors Inc. bought a new stake in Owens & Minor during the 4th quarter worth approximately $466,000. Opus Capital Group LLC bought a new stake in Owens & Minor during the 4th quarter worth approximately $2,937,000. SG Americas Securities LLC increased its stake in Owens & Minor by 12.3% during the 4th quarter. SG Americas Securities LLC now owns 134,397 shares of the company’s stock worth $2,537,000 after purchasing an additional 14,694 shares in the last quarter. Aperio Group LLC increased its stake in Owens & Minor by 17.0% during the 4th quarter. Aperio Group LLC now owns 67,402 shares of the company’s stock worth $1,273,000 after purchasing an additional 9,814 shares in the last quarter. Finally, KBC Group NV bought a new stake in Owens & Minor during the 3rd quarter worth approximately $2,283,000. 96.90% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/04/04/owens-minor-omi-upgraded-by-zacks-investment-research-to-hold-2.html.

About Owens & Minor

Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).

Get a free copy of the Zacks research report on Owens & Minor (OMI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply